|
FBXO11 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.439700E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.606120E-02 |
| Normal-vs-Stage2 |
1.121820E-01 |
| Normal-vs-Stage3 |
7.68560000000695E-05 |
| Normal-vs-Stage4 |
3.9579999999706E-06 |
| Stage1-vs-Stage2 |
7.563400E-01 |
| Stage1-vs-Stage3 |
1.624280E-02 |
| Stage1-vs-Stage4 |
3.344800E-03 |
| Stage2-vs-Stage3 |
3.493600E-01 |
| Stage2-vs-Stage4 |
2.433200E-01 |
| Stage3-vs-Stage4 |
6.833800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.834590E-04 |
| Normal-vs-AfricanAmerican |
5.306500E-02 |
| Normal-vs-Asian |
6.238000E-01 |
| Caucasian-vs-AfricanAmerican |
3.966200E-01 |
| Caucasian-vs-Asian |
1.180630E-01 |
| AfricanAmerican-vs-Asian |
1.905820E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.69900000000145E-05 |
| Normal-vs-Female |
7.352100E-02 |
| Male-vs-Female |
8.503400E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.193870E-02 |
| Normal-vs-Age(41-60Yrs) |
9.222800E-03 |
| Normal-vs-Age(61-80Yrs) |
4.443100E-04 |
| Normal-vs-Age(81-100Yrs) |
1.997800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.654400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.143800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.175200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.060200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.736430E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.130600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.232200E-01 |
| Normal-vs-Grade 2 |
1.262600E-01 |
| Normal-vs-Grade 3 |
1.7011999997596E-07 |
| Normal-vs-Grade 4 |
1.14289999997297E-06 |
| Grade 1-vs-Grade 2 |
1.130380E-01 |
| Grade 1-vs-Grade 3 |
7.817900E-04 |
| Grade 1-vs-Grade 4 |
5.019600E-04 |
| Grade 2-vs-Grade 3 |
2.357400E-04 |
| Grade 2-vs-Grade 4 |
2.209600E-04 |
| Grade 3-vs-Grade 4 |
3.765000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.511000E-01 |
| Normal-vs-ccB subtype |
3.65680000000701E-05 |
| ccA subtype-vs-ccB subtype |
1.403620E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.775480E-03 |
| Normal-vs-N1 |
2.422200E-02 |
| N0-vs-N1 |
6.278600E-01 |
|
|
